Track Nanosonics Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nanosonics Limited NAN.AX · Stock Open Nanosonics Limited in new tab

3.35 AUD
P/E
47.57
EPS
0.07
P/B
4.60
ROE
10.06
Beta
1.21
Target Price
4.30 AUD
Loading chart...
Key Metrics
Earnings dateAug. 24, 2026
P/E47.57
EPS0.07
Book Value0.72
Price to Book4.60
Debt/Equity3.04
% Insiders15.882%
Growth
Revenue Growth0.09%
Earnings Growth-0.01%
Estimates
Forward P/E45.35
Forward EPS0.07
Target Mean Price4.30

DCF Valuation

Tweak assumptions to recompute fair value for Nanosonics Limited (NAN.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nanosonics Limited Logo Nanosonics Limited Analysis (NAN.AX)

Australia Health Care Official Website Stock

Is Nanosonics Limited a good investment? Nanosonics Limited (NAN.AX) is currently trading at 3.35 AUD. Market analysts have a consensus price target of 4.30 AUD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 47.57. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Nanosonics Limited is expected to release its next earnings report on Aug. 24, 2026. The market consensus estimate for Forward EPS is 0.07.

Investor FAQ

Does Nanosonics Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nanosonics Limited?

Nanosonics Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 24, 2026. The company currently has a trailing EPS of 0.07.

Company Profile

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Exchange Ticker
ASX (Australia) NAN.AX
PNK (United States) NNCSF
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion